Enact Holdings (ACT) CEO Rohit Gupta Sells 32,895 Shares at ~$37.6–38.2
Rohit Gupta, President and CEO and a director of Enact Holdings, Inc. (ticker: ACT), reported three separate open-market sales of the issuer's common stock executed on 08/27/2025, 08/28/2025 and 08/29/2025.
Rhea-AI Filing Summary
Rohit Gupta, President and CEO and a director of Enact Holdings, Inc. (ticker: ACT), reported three separate open-market sales of the issuer's common stock executed on 08/27/2025, 08/28/2025 and 08/29/2025. The filings show dispositions of 11,039, 17,856 and 4,000 shares, respectively, at weighted-average sale prices of $38.18, $37.59 and $37.73 per share. Following the transactions, the reporting person beneficially owned 369,755 shares. The Form 4 is signed by a power of attorney for the reporting person.
Positive
- Transparent disclosure of three open-market sales with share counts and weighted-average prices
- Remaining beneficial ownership is clearly reported as 369,755 shares
- Price ranges and willingness to provide trade-level details to the SEC or issuer are explicitly stated
Negative
- Insider disposed of 32,895 shares across three days, reducing direct holdings
- No context provided in the filing about the reason for the sales (e.g., planned sales or personal liquidity)
Insights
TL;DR: Routine, disclosed insider sales by the CEO and director totaling 32,895 shares; no derivatives or additional arrangements reported.
The Form 4 documents three separate open-market sales by Rohit Gupta on consecutive dates with clear share counts and weighted-average prices. The filing indicates direct ownership and does not disclose any derivative holdings. From a governance perspective, the disclosure is straightforward and includes explanatory notes about the price ranges, which preserves transparency. The sale reduced beneficial ownership to 369,755 shares; the filing was executed via power of attorney.
TL;DR: Insider sold 32,895 shares across three days at ~$37.6–$38.2, leaving 369,755 shares; no other material transactions disclosed.
The transaction schedule lists three sell transactions: 11,039 shares at a weighted-average $38.18 on 08/27/2025, 17,856 shares at $37.59 on 08/28/2025, and 4,000 shares at $37.73 on 08/29/2025. The filing supplies range-based price explanations and states the remaining beneficial ownership. There are no reported option exercises, grants, or derivative transactions in Table II.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 4,000 | $37.73 | $151K |
| Sale | Common Stock | 17,856 | $37.59 | $671K |
| Sale | Common Stock | 11,039 | $38.18 | $421K |
Footnotes (3)
- F1. Price indicated is the weighted average sale price as a result of a series of broker-assisted transactions ranging from $38.14 to $38.20 per share. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price within the range upon request by the SEC staff, the issuer, or any security holder of the issuer.
- F2. Price indicated is the weighted average sale price as a result of a series of broker-assisted transactions ranging from $37.45 to $37.77 per share. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price within the range upon request by the SEC staff, the issuer, or any security holder of the issuer.
- F3. Price indicated is the weighted average sale price as a result of a series of broker-assisted transactions ranging from $37.62 to $37.87 per share. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price within the range upon request by the SEC staff, the issuer, or any security holder of the issuer.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions were reported for Enact Holdings (ACT)?
Were any derivative securities or option exercises reported in the Form 4 for ACT?
Who signed the Form 4 for Rohit Gupta?
AI-generated analysis. How Rhea-AI works. Not financial advice.